Study Group: Zoloft Prescribers for Depression (US)(?)
Council Members in this Study Group: 80
Request a survey with this Study Group
Leading Experts in this Study Group
Daniel Wynn, MD
Director, Clinical Research
Consultants In Neurology Ltd.
Daniel Wynn, MD, FACN, FAASM, is a Director of Clinical Research at Consultants in Neurology in Chicago, Illinois. He has expertise in a wide variety of neurological illnesses and has served as a principal investigator in over 100 clinical trials in multiple sclerosis, Alzheimer's disease, stroke, chronic...
Amit Vijapura, MDOwner
Amit Vijapura, MD
Amit Vijapura, MD, is a Private Practitioner in Psychiatry based in Florida. He has over 15 years of experience in the field and has expertise in depression, bipolar disorder, anxiety disorder, attention deficient disorder, and schizophrenia. Dr. Vijapura is board certified in Psychiatry and is also...
Psychiatrist
North Scottsdale Psychiatric Specialists
Robert Schulte, MD, is a Private Practitioner and a Psychiatrist at North Scottsdale Psychiatric Specialists in Arizona. He is board certified in Adult Psychiatry and Child and Adolescent Psychiatry with extensive experience with children and adult's re-psychotherapy and psychopharmacology and the treatment...
President
Red Oak Psychiatry Associates, P. A.
Lawrence Ginsberg, MD, is President and CEO of Red Oak Psychiatry Associates, PA, a multidisciplinary mental health group in Houston, Texas. Dr. Ginsberg's research interests include psychopharmacology, addiction medicine, and forensic psychiatry. His areas of clinical expertise are attention deficit...
Louis Sanfilippo, MDPresident
LCS Group, LLC
Louis Sanfilippo, MD, is President of the LCS Group, since April 2008, a consulting firm focused on pharmaceutical development and market strategy. He is an Assistant Clinical Professor of Psychiatry at Yale School of Medicine and in private practice. Dr. Sanfilippo has served management and scientific...
Related Study Groups
| Study Group Name | Members |
|---|---|
| Physicians who Treat Depression (US) | 381 |
| SSRI Prescribers (US) | 259 |
| Celexa Prescribers for Depression | 75 |
| Physicians who Treat ADHD (US) | 434 |
| Psychiatrists (US) | 1116 |
| Psychiatrists | 1458 |
| Effexor XR Prescribers (US) | 139 |
GLG NewsSMAnalyses by this Study Group's Leading Experts(?)
I agree with the premise of the article -- that diuretics may be underutilized as a cheap way to get the benefits of antihypertensives. However, more than 40% of my HTN patients are on diuretics, and I think the data presented in the NY Times article may be flawed. Here's why:
This study reveals the nature of the disease- it affects both men and women. This study confirms the benefit of use of Gardasil in boys and men.
This article tells you only that the drugs are equally effective, but not what that really means in real life.
Abuse resistant long acting narcotics offer benefit as they are less desirable to those who might wish a quick high via snorting, injecting crushed time-release narcotic. Unfortunately, given the higher cost than long acting generics and increased pressure on physicians to prescribe generics, expect...
Astra Zeneca is pursuing important medical and, of course, commercial goals by seeking the expanded clinical indications of major depression and generalized anxiety disorder for Seroquel XR, heir to blockbuster Seroquel (quetiapine). This latest EU submission culminates regulatory submissions...
Most Common Company Types:
- Office Based Private Practice or Clinic
- Academic Medical Center/Hospital or Clinic
- Non-Academic Community Hospital or Clinic
Most Common Job Types:
- Physician - Attending Physician
- Owner
- Physician - Director
- Director
- Medical Director
- President
- Physician - Division Head
- Partner
GLG's 750+ Clients Include:
global mutual funds
global banks
private equity firms